The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...
ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...
Medically reviewed by Aviv Joshua, MS, RDN Purple carrots contain anthocyanin antioxidants that support your eye health and may lower your risk of cataracts.Eating purple carrots may protect your ...
Function Health raised a $298 million Series B round, pushing its valuation into unicorn territory at $2.5 billion. The ...
The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...
• Investigations of anorectal structure, function and sensation are indicated for the assessment of patients with symptoms suggestive of an evacuation disorder and/or faecal incontinence that are ...
The trial is a phase 1/2 open-label, ascending-dose study of the safety and efficacy of OPGx-LCA5. Recently, the company ...
About a year ago, a test revealed that I had an 8-mm stone in my kidney. My kidney doctor was not worried about it. I have ...
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...
My primary care doctor has prescribed the medication Evenity for my osteoporosis. I have been on Fosamax for about three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback